From January 1, 2024 to March 31, 2024, the company has repurchased 9,701,000 shares, representing 0.51% for CNY 37.39 million. With this, the company has completed the repurchase of 37,232,540 shares, representing 1.93% for CNY 164.86 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.03 CNY | +0.25% | +1.77% | -9.23% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.23% | 1.06B | |
+43.96% | 6.34B | |
-15.56% | 4.51B | |
-6.52% | 3.29B | |
+5.47% | 3.2B | |
-0.76% | 2.59B | |
+56.34% | 2.09B | |
-4.11% | 1.76B | |
+2.93% | 1.7B | |
-8.02% | 1.62B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.